There are currently 299 active clinical trials seeking participants for Cancer research studies. The states with the highest number of trials for Autism participants are California, Texas, New York and Florida.
Building Empowerment and Coping Outcomes for caNcer Patients, Survivors and Their Caregivers
NCT06353178
Recruiting
Cancer has a psychological, emotional and social impact beyond a patient's physical health. This study examines three new online peer mental-wellness support program for cancer patients, survivors or their caregivers. Each program teaches evidence-based skills, in the context of that groups lived experience, to manage the emotional impact of cancer. This study examines the impact of that program.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/05/2024
Locations: Color Health, Burlingame, California
Conditions: Cancer, Caregiving Stress, Caregiver Burnout, Survivorship
Register for Updates
Expanding Clinical Trial Awareness Among Black Communities Through Digital Engagement
NCT06218615
Recruiting
Under-representation of patients from racial/ethnic minority groups in cancer clinical trials is a major barrier to health equity. Black patients are significantly less likely to be enrolled in clinical trials compared with non-Hispanic White (White) patients although they carry a disproportionate burden of cancer mortality, the shortest survival rates, and are more likely to be diagnosed at later stages. Further, medical mistrust and lack of awareness and complexity of clinical trials are barri... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/05/2024
Locations: Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington
Conditions: Cancer
Register for Updates
Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors
NCT04717375
Recruiting
The study will enroll advanced cancer patients with unresectable or metastatic disease who are refractory to or are not candidates for standard approved therapy. The study will be comprised of two parts - a dose escalation phase (Part 1) and a dose optimization/expansion phase (Part 2). Part 1 is comprised of three sub-parts: SAR444881 administered alone (Sub-Part 1A), SAR444881 administered in combination with pembrolizumab (Sub-Part 1B), and SAR444881 administered in combination with cetuximab... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
04/02/2024
Locations: Mayo Clinic, Phoenix, Arizona +9 locations
Conditions: Cancer, Neoplasm
Register for Updates
A Randomized Trial of a Mobile Health Exercise Intervention for Older Adults With Myeloid Neoplasms
NCT04981821
Recruiting
This is a phase 2 randomized controlled trial (RCT) to assess the preliminary efficacy of the a mobile health exercise intervention (GO-EXCAP) versus a chemotherapy education control in 100 older patients with MN receiving outpatient chemotherapy on physical function and patient-reported outcomes (fatigue, mood, and quality of life). We will also explore the effect of the intervention on TNFα and related cytokine gene promoter methylation and their gene and protein expression.
Gender:
All
Ages:
60 years and above
Trial Updated:
04/02/2024
Locations: University of Rochester Medical Center/Wilmot Cancer Institute, Rochester, New York
Conditions: Cancer, Myeloid Neoplasm
Register for Updates
Umbrella Study for Analysis of Data Related to Patients With Cancer
NCT06018753
Recruiting
This study is a multisite, minimal risk, non-interventional study using patient electronic health record data collected as part of standard of care to answer cohort-based research questions and create robust real-world data sets.
Gender:
All
Ages:
All
Trial Updated:
04/02/2024
Locations: MemorialCare, Long Beach, California +4 locations
Conditions: Cancer
Register for Updates
Exercise and Cognitive Rehab in Older Cancer Survivors
NCT05388214
Recruiting
The objective of the study is to evaluate the feasibility of a combined mobile health exercise and cognitive rehabilitation intervention and its effect on cognition in a single-arm pilot study that recruits cancer survivors.
Gender:
All
Ages:
60 years and above
Trial Updated:
04/01/2024
Locations: University of Rochester, Rochester, New York
Conditions: Cancer
Register for Updates
Durvalumab in Combination With Tremelimumab in Subjects With Advanced Rare Solid Tumors
NCT02938793
Recruiting
This is an investigator initiated single institution, open-label study to evaluate the antitumor activity, safety, and tolerability of durvalumab in combination with tremelimumab in subjects with select advanced rare solid tumors.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/01/2024
Locations: Greenville Health System Cancer Institute, Greenville, South Carolina
Conditions: Cancer, Rare Disease
Register for Updates
The HealthScore Health Coaching Program
NCT04923997
Recruiting
Purpose: The HealthScore Health Coaching Program aims to deliver 6-months of 1:1 home-based health coaching to cancer patients receiving treatment and survivors of any diagnosis at UNC Cancer Hospital. This study hopes to preserve physical function, address unmet physical, nutritional, psychological, social and other needs. Procedures: This will be done through individualized health coaching, weekly symptom survey administration, monthly supportive care questionnaires, and physical assessments... Read More
Gender:
All
Ages:
15 years and above
Trial Updated:
03/28/2024
Locations: University of North Carolina, Chapel Hill, North Carolina
Conditions: Cancer, Survivorship, Quality of Life, Health Behavior
Register for Updates
Educational Video for Genetic Testing
NCT05472714
Recruiting
Develop and evaluate the acceptability, feasibility, and preliminary efficacy of an informational video on paired tumor/normal testing for children and adolescents with a new diagnosis of cancer, tumors or other diagnosis.
Gender:
All
Ages:
12 years and above
Trial Updated:
03/27/2024
Locations: Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
Conditions: Genetic Disease, Cancer
Register for Updates
Impact of the Therapeutic Alliance on Reduction of Disparities in Latino End-of-Life Cancer Care
NCT04342611
Recruiting
The purpose of the study is to examine perceptions, barriers, and facilitators of a therapeutic alliance (TA) between Latino/a advanced cancer patients and their oncologists. We aim to qualitatively explore patient and oncologist perceptions of TA, barriers and facilitators of TA, and the perceived influence of Latino/a ethnicity on TA via in-depth interviews with oncologists (N=4) and focus groups with patients (N=10 patients). We hypothesize that we will be able to better understand the TA bet... Read More
Gender:
All
Ages:
21 years and above
Trial Updated:
03/25/2024
Locations: City of Hope Medical Center, Duarte, California
Conditions: Cancer
Register for Updates
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors
NCT04673942
Recruiting
AdAPT-001 is an oncolytic virus that is injected directly into the tumor or via intraarterial administration. The purpose of this study is to find out if AdAPT-001 is safe and tolerable. The next step is to find out if AdAPT-001 if efficacious with or without a checkpoint inhibitor.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/22/2024
Locations: City of Hope, Duarte, California +5 locations
Conditions: Solid Tumor, Adult, Cancer, Neoplasms, Sarcoma, Sarcoma,Soft Tissue, Chondrosarcoma
Register for Updates
An Evaluation of the Implementation of the Care and Monitoring at Home Program- A New Paradigm for Acute Care Management of Cancer Patients
NCT05904899
Recruiting
To understand the experience of patients receiving care in the Care and Monitoring at Home program at MD Anderson. Researchers intend to use this information to study and possibly improve the hospital care at home program.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/22/2024
Locations: MD Anderson Cancer Center, Houston, Texas
Conditions: Cancer
Register for Updates